I don't think so. But we are certainly trying to lower the barrier to entry for building useful biological tools. We hope to help 'smaller than billion-dollar-blockbuster drugs' be built by companies and researchers who are inventing all sorts of socially useful biological technologies. We are working with scientists to enable novel uses of biotechnologies for things like genetically targeted immunotherapies, synthetic biosensors, spider silk clothing, vegan gelatins meats and milks, oil-free biofuel production, and of course just much more rapid biological research.
